These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11085568)

  • 61. Leukaemia inhibitory factor increases myoblast replication and survival and affects extracellular matrix production: combined in vivo and in vitro studies in post-natal skeletal muscle.
    White JD; Davies M; Grounds MD
    Cell Tissue Res; 2001 Oct; 306(1):129-41. PubMed ID: 11683174
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Amelioration of collagen antibody induced arthritis in mice by an antibody directed against the fibronectin type III repeats of tenascin-C: Targeting fibronectin type III repeats of tenascin-C in rheumatoid arthritis.
    Mehta BB; Tiwari A; Sharma S; Shukla A; Sharma M; Vasishta RK; Sen RK; Sharma A; Luthra-Guptasarma M
    Int Immunopharmacol; 2018 May; 58():15-23. PubMed ID: 29529488
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Loading of healing bone, fibrous tissue, and muscle: implications for orthopaedic practice.
    Buckwalter JA; Grodzinsky AJ
    J Am Acad Orthop Surg; 1999; 7(5):291-9. PubMed ID: 10504356
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hippocampal loss of tenascin boundaries in Ammon's horn sclerosis.
    Scheffler B; Faissner A; Beck H; Behle K; Wolf HK; Wiestler OD; Blümcke I
    Glia; 1997 Jan; 19(1):35-46. PubMed ID: 8989566
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tenascin-R and C in multiple sclerosis lesions: relevance to extracellular matrix remodelling.
    Gutowski NJ; Newcombe J; Cuzner ML
    Neuropathol Appl Neurobiol; 1999 Jun; 25(3):207-14. PubMed ID: 10417662
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Extracellular matrix signaling through growth factor receptors during wound healing.
    Tran KT; Griffith L; Wells A
    Wound Repair Regen; 2004; 12(3):262-8. PubMed ID: 15225204
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapeutics for tendon regeneration: a multidisciplinary review of tendon research for improved healing.
    Paredes JJ; Andarawis-Puri N
    Ann N Y Acad Sci; 2016 Nov; 1383(1):125-138. PubMed ID: 27768813
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tenascin-C inhibits beta1 integrin-dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1-5 repeats to fibronectin.
    Hauzenberger D; Olivier P; Gundersen D; Rüegg C
    Eur J Immunol; 1999 May; 29(5):1435-47. PubMed ID: 10359097
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biologic scaffolds for musculotendinous tissue repair.
    Turner NJ; Badylak SF
    Eur Cell Mater; 2013 Jan; 25():130-43. PubMed ID: 23329468
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ROCK controls matrix synthesis in vascular smooth muscle cells: coupling vasoconstriction to vascular remodeling.
    Chapados R; Abe K; Ihida-Stansbury K; McKean D; Gates AT; Kern M; Merklinger S; Elliott J; Plant A; Shimokawa H; Jones PL
    Circ Res; 2006 Oct; 99(8):837-44. PubMed ID: 16990566
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tenascin expression during wound healing in human skin.
    Latijnhouwers MA; Bergers M; Van Bergen BH; Spruijt KI; Andriessen MP; Schalkwijk J
    J Pathol; 1996 Jan; 178(1):30-5. PubMed ID: 8778312
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chondroitin sulfates expressed on oligodendrocyte-derived tenascin-R are involved in neural cell recognition. Functional implications during CNS development and regeneration.
    Probstmeier R; Stichel CC; Müller HW; Asou H; Pesheva P
    J Neurosci Res; 2000 Apr; 60(1):21-36. PubMed ID: 10723065
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tenascin-C in peripheral nerve morphogenesis.
    Chiquet M; Wehrle-Haller B
    Perspect Dev Neurobiol; 1994; 2(1):67-74. PubMed ID: 7530145
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tenascin-C expression in human epidermal keratinocytes is regulated by inflammatory cytokines and a stress response pathway.
    Latijnhouwers MA; Pfundt R; de Jongh GJ; Schalkwijk J
    Matrix Biol; 1998 Aug; 17(4):305-16. PubMed ID: 9749946
    [TBL] [Abstract][Full Text] [Related]  

  • 75. mRNA expression and protein distribution of the unspliced tenascin-C isoform in prostatic adenocarcinoma.
    Katenkamp K; Berndt A; Hindermann W; Wunderlich H; Haas KM; Borsi L; Zardi L; Kosmehl H
    J Pathol; 2004 Jul; 203(3):771-9. PubMed ID: 15221936
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Enhanced tenascin-C expression and matrix deposition during Ras/TGF-beta-induced progression of mammary tumor cells.
    Maschler S; Grunert S; Danielopol A; Beug H; Wirl G
    Oncogene; 2004 Apr; 23(20):3622-33. PubMed ID: 15116096
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The extracellular matrix protein betaIG-H3 is expressed at myotendinous junctions and supports muscle cell adhesion.
    Ferguson JW; Thoma BS; Mikesh MF; Kramer RH; Bennett KL; Purchio A; Bellard BJ; LeBaron RG
    Cell Tissue Res; 2003 Jul; 313(1):93-105. PubMed ID: 12838408
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Platelet-derived growth factor-BB mediates cell migration through induction of activating transcription factor 4 and tenascin-C.
    Malabanan KP; Sheahan AV; Khachigian LM
    Am J Pathol; 2012 Jun; 180(6):2590-7. PubMed ID: 22507839
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The tenascin-C knockout revisited.
    Mackie EJ; Tucker RP
    J Cell Sci; 1999 Nov; 112 ( Pt 22)():3847-53. PubMed ID: 10547346
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Advances in tenascin-C biology.
    Midwood KS; Hussenet T; Langlois B; Orend G
    Cell Mol Life Sci; 2011 Oct; 68(19):3175-99. PubMed ID: 21818551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.